Skip to content
Screener

Evolent Health, Inc. EVH Equity Method Income

Equity Method Income at other companies

Xcel Energy logo
Xcel EnergyXEL
$13M+1,400%
Semtech logo
SemtechSMTC
$1.62M+55.0%
Blackstone Mortgage Trust logo
Blackstone Mortgage TrustBXMT
$1.38M+258%
Amcor logo
AmcorAMCR
$0
NexPoint Real Estate Finance logo
NexPoint Real Estate FinanceNREF
$54K+1.9%
Hewlett Packard Enterprise logo
Hewlett Packard EnterpriseHPE
$25M0.0%

Segments

By segment

See full
Reportable segment$197K

Other financials

Income statement

See full
Revenue$652.5M+46.9%
Gross profit$80.8M-19.5%
Operating income-$9.6M-716%
Net income-$28.4M-42.6%
EPS (diluted)-$0.25+43.2%

Balance sheet

See full
Cash & equivalents$115.7M-23.4%
Total debt$970.4M+13.7%
Total equity$383.2M-57.2%
Total assets$2.0B-19.9%

Cash flow

See full
Operating cash flow-$9.3M+69.3%

Valuation

See full
Market cap$446.58M-58.2%
Enterprise value$1.3B-26.5%
P/S0.2×-0.3×

Profitability

See full
Gross margin17.2%+0.9pp
Operating margin-20.4%-22.4pp
Net margin-24.1%-35.8pp
FCF margin-9.7%

Returns & leverage

See full
Return on equity-79%-99.2pp
Debt / equity2.5×+1.6×
Current ratio1.2×+0.2×

Where this comes from

Reported directly by Evolent Health, Inc. in its filing.

Tagged under the XBRL concept us-gaap:IncomeLossFromEquityMethodInvestments.

The source filing: Evolent Health, Inc.’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 8:53 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001628908-26-000086
Line itemFor the Three Months Ended June 30, 2026For the Three Months Ended June 30, 2025For the Six Months Ended June 30, 2026For the Six Months Ended June 30, 2025
Operating loss(9,561)(1,171)(20,160)(2,793)
Interest income7031,0841,7172,358
Interest expense(16,859)(11,601)(33,727)(21,986)
Gain (loss) from equity method investees(41)197(52)178
Loss on option exercise(196)(52,544)
Extinguishment of Series A Preferred Stock and other refinancing fees(9,000)(9,000)
Other income (expense), net109(35)851(83)
Loss before income taxes(25,649)(20,722)(51,371)(83,870)

Item 1. Financial Statements

FAQ

What is Evolent Health, Inc.'s equity method income?
Evolent Health, Inc. (EVH) reported equity method income of -$41K in Q2 2026.
How has Evolent Health, Inc.'s equity method income changed year-over-year?
Evolent Health, Inc.'s equity method income decreased by 120.8% year-over-year, from $197K to -$41K.
What is the long-term trend for Evolent Health, Inc.'s equity method income?
Over 4 years (2021 to 2025), Evolent Health, Inc.'s equity method income has grown at a -59.2% compound annual growth rate (CAGR), from $13.18M to $365K.
What does equity method income mean?
The company's proportional share of net income or loss from unconsolidated affiliates and joint ventures accounted for under the equity method.

Ask your AI about Evolent Health, Inc.'s equity method income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude